News - University of Louisville
Some patients with advanced heart failure caused by cardiomyopathy, the deterioration of function of the heart muscle, are getting a new lease on life thanks to an innovative treatment program at Jewish Hospital, a part of KentuckyOne Health, and the University of Louisville.
A newly developed, genetically modified pig may hold the keys to the development of improved treatments and possibly even a cure for retinitis pigmentosa (RP), the most common inherited retinal disease in the United States.
Organ transplant patients usually spend a lifetime on expensive and often dangerous anti-rejection drugs. But experts have announced that such drugs may not even be needed in the future.
First-of-its-kind study where donor, recipient are not related or immunologically matched CHICAGO, March 7, 2012 /PRNewswire-USNewswire/ -- New ongoing research published
Contact: Jessica H. NixVice President of Marketing404-920-5351jnix@peakcampus.com
